Mogamulizumab-kpkc

(moh-GAM-yoo-LIH-zoo-mab)

This page contains brief information about mogamulizumab-kpkc and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Poteligeo
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Mogamulizumab-kpkc is approved to treat:

Mogamulizumab-kpkc is also being studied in the treatment of other types of cancer.

More About Mogamulizumab-kpkc

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Clinical Trials Accepting Patients

Find Clinical Trials for Mogamulizumab-kpkc - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: August 30, 2018